Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Antunes, J. Gomes, C. Lima, P. Brinca, J. C. Machado, B. Parente (Vila Nova Gaia, Porto, Portugal; Stckholm, Sweden). EGFR – a useful biomarker?. Eur Respir J 2009; 34: Suppl. 53, 2663

Member's Comments

No comment yet.

Related content which might interest you: LungPoint® – A new approach to peripheral lung lesions Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy Year: 2010 TTF-1 in advanced SCLC – Diagnostic and prognostic relevance Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 6-minute-walk in lung cancer – a new predictor for response and the performance status? Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009 Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function? Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010 Documentation & accuracy of smoking status – An educational need? Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders Year: 2011 Freeflowmetry – The new method of evaluation of the respiratory function phenotype Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011 Adrenomedullin – a protective factor in asthma? Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Triple 0 – A new respiratory syndrome? Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts Year: 2012 Ways to shorten the lung clearance index measurement ΙΙ – How long to wash? Source: Annual Congress 2012 - New developments in paediatric respiratory physiology Year: 2012 Multiple kinds of cancer in one person – Lung and breast cancer – And other malignant entities Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010 How should we investigate the child with difficult asthma – Is there any evidence? Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma Year: 2010 Finding the missing millions with COPD – Does it work? Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management Year: 2012 EGFR and hTERT expression in high risk COPD patients – clinical application Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Ways to shorten the lung clearance index measurement I – Are three measurements needed? Source: Annual Congress 2012 - New understanding of childhood lung disease through physiological measurement Year: 2012 Evaluation of difficult asthma – a single centre experience Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 HbA1c in pulmonary arterial hypertension – A marker of prognostic relevance? Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Pulmonary rehabilitation in patients with interstitial lung disease – An useful therapeutic option? Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011 Tuberculosis – An important risk factor for lung cancer Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 T spot TB reactivity – ²to treat or not to treat² Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Freeflowmetry – The proposal of the new method of evaluation of the respiratory function phenotype Source: Annual Congress 2010 - Advances in lung function II Year: 2010